Evidence map›Paper›PMID 31796819›Full record

ArticleScientific reports2019

FOXO3a regulates rhinovirus-induced innate immune responses in airway epithelial cells.

Joao Gimenes-Junior, Nicole Owuar, Hymavathi Reddy Vari, Wuyan Li, Nathaniel Xander, Sudhir Kotnala, Uma S Sajjan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort.The journal of allergy and clinical immunology. Global · 2025
    Article
  4. Article
  5. In Vivo Model to Assess the Nasal Infection by Minor Group Rhinovirus.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. mBio · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2020
    Review
  15. Rhinovirus and Innate Immune Function of Airway Epithelium.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joao Gimenes-JuniorDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Nicole OwuarDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Hymavathi Reddy VariDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Wuyan LiDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Nathaniel XanderDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Sudhir KotnalaDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA.
Uma S SajjanDepartment of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA. uma.sajjan@temple.edu.
Temple University · US

Funding

Quercetin prevents progression of COPD lung disease by modulating Foxo3AactivityR01AT007620 · NCCIH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAJJAN, UMADEVI SIVANAPPA · 2014 to 2018
$2.0M
NCCIH NIH HHS R01 AT007620
6 · The paper itself

Abstract

Forkhead transcription factor class O (FOXO)3a, which plays a critical role in a wide variety of cellular processes, was also found to regulate cell-type-specific antiviral responses. Airway epithelial cells express FOXO3a and play an important role in clearing rhinovirus (RV) by mounting antiviral type I and type III interferon (IFN) responses. To elucidate the role of FOXO3a in regulating antiviral responses, we generated airway epithelial cell-specific Foxo3a knockout (Scga1b1-Foxo3a-/-) mice and a stable FOXO3a knockout human airway epithelial cell line. Compared to wild-type, Scga1b1-Foxo3a-/- mice show reduced IFN-α, IFN-β, IFN-λ2/3 in response to challenge with RV or double-stranded (ds)RNA mimic, Poly Inosinic-polycytidylic acid (Poly I:C) indicating defective dsRNA receptor signaling. RV-infected Scga1b1-Foxo3a-/- mice also show viral persistence, enhanced lung inflammation and elevated pro-inflammatory cytokine levels. FOXO3a K/O airway epithelial cells show attenuated IFN responses to RV infection and this was associated with conformational change in mitochondrial antiviral signaling protein (MAVS) but not with a reduction in the expression of dsRNA receptors under unstimulated conditions. Pretreatment with MitoTEMPO, a mitochondrial-specific antioxidant corrects MAVS conformation and restores antiviral IFN responses to subsequent RV infection in FOXO3a K/O cells. Inhibition of oxidative stress also reduces pro-inflammatory cytokine responses to RV in FOXO3a K/O cells. Together, our results indicate that FOXO3a plays a critical role in regulating antiviral responses as well as limiting pro-inflammatory cytokine expression. Based on these results, we conclude that FOXO3a contributes to optimal viral clearance and prevents excessive lung inflammation following RV infection.

Indexed as

AnimalsCells, CulturedCytokinesEpithelial CellsFemaleForkhead Box Protein O3Gene Expression RegulationImmunity, InnateInterferonsMaleMiceMice, KnockoutPicornaviridae InfectionsPoly I-CRespiratory MucosaRhinovirusCytokinesForkhead Box Protein O3FoxO3 protein, mouseInterferonsPoly I-C

Identifiers

PMID31796819
PMCPMC6890790
OpenAlexW2994365379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.